FrancophonIA/ELRC3.0 huggingface dataset:
English: For practical information about using Panacur AquaSol, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Croatian: Praktične informacije o primjeni VMP-a Panacur AquaSol vlasnici životinja ili uzgajivači trebaju pročitati u uputi o VMP-u, odnosno trebaju se obratiti svojem veterinaru ili ljekarniku.
English: For more information about treatment with Panacur AquaSol, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Croatian: Dodatne informacije o terapiji VMP-om Panacur AquaSol vlasnici životinja ili uzgajivači trebaju pročitati u uputi o VMP-u, odnosno trebaju se obratiti svojem veterinaru ili ljekarniku.
English: The withdrawal period for Panacur AquaSol for pig meat and offal is four days.
Croatian: Razdoblje karencije za meso i iznutrice svinje liječene VMP-om iznosi četiri dana.
English: • Ascaris suum (adult intestinal and migrating larval stages);
Croatian: • Ascaris suum (odrasli stadij, crijevna i migracijska ličinka)
English: How does Panacur AquaSol work?
Croatian: Kako djeluje Panacur AquaSol?
English: What benefits of Panacur AquaSol have been shown in studies?
Croatian: Koje su koristi VMP-a Panacur AquaSol utvrđene u ispitivanjima?
English: • Heterakis gallinarum (L5 larvae and adult stages);
Croatian: • Heterakis gallinarum (ličinke stadija L5 i odrasli stadiji)
English: • Capillaria worms (L5 larvae and adult stages).
Croatian: • crvi Capillaria (ličinke stadija L5 i odrasli stadiji).
English: • Ascaridia galli (L5 larvae and adult stages);
Croatian: • Ascaridia galli (ličinke stadija L5 i odrasli stadiji)
English: How is Panacur AquaSol used?
Croatian: Kako se Panacur AquaSol koristi?
English: For pigs, Panacur AquaSol is added to their drinking water in a quantity that aims to supply each pig 2.5 mg fenbendazole per kg bodyweight daily; this is done for two consecutive days for treatment and control of Ascaris suum and Oesophagostomum infections, and for three consecutive days to treat and control Trichuris suis.
Croatian: Za svinje se Panacur AquaSol dodaje u njihovu vodu za piće u količini koja svakoj svinji treba omogućiti dozu od 2,5 mg fenbendazola po kg tjelesne težine dnevno.
English: This overview was last updated in September 2018.
Croatian: Pregled je posljednji put ažuriran u rujnu 2018.
English: Inflacam (meloxicam)
Croatian: Inflacam (meloksikam)
English: Injections may be into a vein, muscle or under the skin.
Croatian: Injekcije se mogu davati u venu, mišić ili pod kožu.
English: Other information about Inflacam
Croatian: Ostale informacije o VMP-u Inflacam
English: Inflacam can only be obtained with a prescription.
Croatian: Inflacam se izdaje samo na recept.
English: Inflacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs and cats.
Croatian: Inflacam je protuupalni lijek koji se primjenjuje u goveda, svinja, konja, pasa i mačaka.
English: Septicaemia and toxaemia are conditions where bacteria circulate in the blood and produce harmful substances (toxins).
Croatian: Septikemija i toksemija su stanja u kojima bakterija kruži u krvi i proizvodi štetne tvari (toksine).
English: Further information on Inflacam can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary Medicines/European public assessment reports Information on the reference medicine can also be found on the Agency's website.
Croatian: Više informacija o VMP-u Inflacam nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary Medicines/European public assessment reports
English: This means that Inflacam contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Metacam.
Croatian: To znači da Inflacam sadržava istu djelatnu tvar i djeluje na isti način kao i „referentni VMP” koji je već odobren u Europskoj uniji (EU) pod nazivom Metacam.
English: What is Inflacam and what is it used for?
Croatian: Što je Inflacam i za što se primjenjuje?
English: Why is Inflacam authorised in the EU?
Croatian: Zašto je Inflacam odobren u EU-u?
English: The withdrawal period for meat is five days for the 20 mg/ml solution for injection and three days for the granules and 15 mg/ml oral suspension.
Croatian: Razdoblje karencije za meso iznosi pet dana za otopinu za injekciju od 20 mg/ml te tri dana za granule i peroralnu suspenziju od 15 mg/ml.
English: What are the benefits and risks of Inflacam?
Croatian: Koje su koristi i rizici od VMP-a Inflacam?
English: The formulation and dose to use depends on the animal and the condition being treated.
Croatian: Oblik i doza koji će se primijeniti ovise o životinjskoj vrsti i stanju koje se liječi.
English: Inflacam received a marketing authorisation valid throughout the EU on 9 December 2011.
Croatian: VMP Inflacam dobio je odobrenje za stavljanje u promet koje vrijedi na prostoru EU-a od 9. prosinca
English: An overview of Inflacam and why it is authorised in the EU
Croatian: Pregled informacija o VMP-u Inflacam i zašto je odobren u EU-u
English: The withdrawal period for meat is 15 days and for milk it is five days.
Croatian: Razdoblje karencije za meso iznosi 15 dana, a za mlijeko pet dana.
English: Inflacam contains meloxicam, which belongs to a class of medicines called non-steroidal antiinflammatory drugs (NSAIDs).
Croatian: Inflacam sadrži meloksikam, koji pripada skupini lijekova zvanih nesteroidni protuupalni lijekovi (NSAID).
English: Meloxicam acts by blocking an enzyme called cyclo-oxygenase which is involved in the production of prostaglandins.
Croatian: Meloksikam djeluje blokadom enzima ciklooksigenaze koji je uključen u proizvodnju prostaglandina.
English: It is also the time required after administration of a medicine before the milk may be used for human consumption.
Croatian: To je također vrijeme koje treba proći nakon primjene VMP-a prije nego što se mlijeko smije upotrijebiti za prehranu ljudi.
English: It can be used with oral re-hydration therapy (medicines given by mouth to restore water levels in the body) to reduce diarrhoea in calves of over one week of age and young, non-lactating cattle.
Croatian: Može se primjenjivati u kombinaciji s oralnom rehidracijskom terapijom (lijekovi koji se daju kroz usta kako bi se obnovila razina vode u tijelu) radi smanjenja proljeva u teladi starije od tjedan dana i mladih goveda koja nisu u laktaciji.
English: The medicine is not authorised for use in horses producing milk for human consumption.
Croatian: VMP nije odobren za primjenu u konja od kojih se dobiva mlijeko za prehranu ljudi.
English: The European Medicines Agency concluded that, in accordance with EU requirements, Inflacam has been shown to have comparable quality and to be bioequivalent to Metacam.
Croatian: Europska agencija za lijekove zaključila je kako je, u skladu sa zahtjevima EU-a, utvrđeno da Inflacam posjeduje usporedivu kakvoću te da je bioekvivalentan lijeku Metacam.
English: Because Inflacam is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je Inflacam generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: Therefore the Agency's view was that, as for Metacam, the benefits of Inflacam outweigh the identified risks and it can be authorised for use in the EU.
Croatian: Stoga je stav Agencije da, kao i kod VMP-a Metacam, koristi Inflacama nadmašuju identificirane rizike te da VMP može biti odobren za primjenu u EU-u.
English: For further information about using Inflacam, see the package leaflet or contact your veterinarian or pharmacist.
Croatian: Za dodatne informacije o primjeni VMP-a Inflacam pogledajte uputu o VMP-u ili se obratite veterinaru ili ljekarniku.
English: In cattle, Inflacam is used together with appropriate antibiotic therapy, to reduce clinical signs of acute respiratory infection (infection of the lungs and airways).
Croatian: U goveda se lijek Inflacam primjenjuje zajedno s odgovarajućom antibiotskom terapijom radi smanjenja znakova akutne respiratorne infekcije (infekcije pluća i dišnih putova).
English: As prostaglandins are substances that trigger inflammation, pain, exudation (fluid that leaks out of blood vessels during an inflammation) and fever, meloxicam reduces these signs of disease.
Croatian: S obzirom na to da su prostaglandini tvari koje potiču upalu, bol, eksudaciju (tekućinu koja curi iz krvnih žila tijekom upale) i vrućicu, meloksikam smanjuje te znakove bolesti.
English: Since Inflacam is a generic medicine, studies have been conducted to determine that it is bioequivalent to the reference medicine, Metacam.
Croatian: Budući da je Inflacam generički lijek, provedena su ispitivanja kako bi se utvrdila bioekvivalentnost s referentnim lijekom Metacam.
English: In pigs, Inflacam is used to reduce lameness and inflammation in non-infectious locomotor disorders (diseases that affect the ability to move), for the relief of post-operative pain after minor soft tissue surgery such as castration, and for supportive therapy together with appropriate antibiotic therapy in the treatment of diseases that occur after farrowing (giving birth) such as puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Croatian: U svinja se lijek Inflacam primjenjuje u slučaju neinfektivnih poremećaja lokomotornog sustava (bolesti koje utječu na sposobnost kretanja) radi smanjenja simptoma hromosti i upale, za ublažavanje postoperativnih bolova povezanih s manjim kirurškim zahvatima u mekanom tkivu poput kastracije te kao potporna terapija uz prikladnu antibiotsku terapiju u liječenju bolesti koje mogu nastupiti nakon prasenja (okota) poput puerperalne septikemije i toksemije (sindrom mastitis-metritis-agalakcija).
English: Inflacam is available as granules, an oral (taken by mouth) suspension , chewable tablets and solution for injection .
Croatian: Lijek Inflacam dostupan je u obliku granula, peroralne suspenzije (primjena kroz usta), tableta za žvakanje i otopine za injekciju.
English: How does Inflacam work?
Croatian: Kako djeluje Inflacam?
English: In horses, Inflacam is used to reduce pain associated with colic (abdominal pain) and to lessen inflammation and relieve pain in acute and chronic musculo-skeletal disorders (disorders affecting the muscles and bones).
Croatian: U konja se lijek Inflacam primjenjuje za ublažavanje bolova povezanih s kolikama (abdominalni bol) te za ublažavanje upale i bolova u akutnih i kroničnih mišićno-koštanih poremećaja (poremećaja koji utječu na mišiće i kosti).
English: Safety information has been included in the summary of product characteristics and the package leaflet for Inflacam, including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers.
Croatian: U sažetku opisa svojstava, kao i u uputi o VMP-u Inflacam, nalaze se informacije o sigurnosti primjene, uključujući odgovarajuće mjere opreza kojih se veterinari te vlasnici životinja ili uzgajivači trebaju pridržavati.
English: Inflacam contains the active substance meloxicam and is a generic medicine.
Croatian: Inflacam sadržava djelatnu tvar meloksikam te je „generički lijek”.
English: Moreover it is used to lessen inflammation and pain in acute and chronic musculo-skeletal disorders in cats.
Croatian: Nadalje, primjenjuje se za olakšavanje upale i bolova u akutnih i kroničnih mišićno-koštanih poremećaja u mačaka.
English: The withdrawal period is the time required after administration of a medicine before an animal can be slaughtered and the meat used for human consumption.
Croatian: Razdoblje karencije vrijeme je koje treba proći od primjene VMP-a do klanja životinje i upotrebe mesa za prehranu ljudi.
English: Moreover, it is used to lessen inflammation and pain in acute and chronic musculo-skeletal disorders.
Croatian: Nadalje, primjenjuje se za olakšavanje upale i bolova u akutnih i kroničnih mišićno-koštanih poremećaja.
English: In cats, Inflacam is used to reduce post-operative pain and inflammation after ovariohysterectomy (spaying operation), orthopaedic and minor soft tissue surgery.
Croatian: U mačaka se Inflacam primjenjuje za smanjenje postoperativnog bola i upale nakon ovariohisterektomije (operacija sterilizacije), ortopedskih i manjih kirurških zahvata na mekanom tkivu.
English: It can also be used as supportive therapy in the treatment of acute mastitis (inflammation of the udder), in combination with antibiotics.
Croatian: Može se primjenjivati i u kombinaciji s antibioticima kao potporna terapija za liječenje akutnog mastitisa (upala vimena).
English: In dogs, Inflacam is used to reduce post-operative pain and inflammation following orthopaedic (e.g. fracture operation) and soft tissue surgery.
Croatian: Inflacam se u pasa primjenjuje za ublažavanje postoperativnog bola i upale nakon ortopedskog zahvata (primjerice operacije frakture) i kirurškog zahvata na mekanom tkivu.
English: How is Inflacam used?
Croatian: Kako se Inflacam primjenjuje?
English: How has Inflacam been studied?
Croatian: Kako je VMP Inflacam ispitivan?
English: This summary was last updated in 04-2014.
Croatian: Sažetak je posljednji put ažuriran u 04. 2014.
English: The dose is given to the baby during or immediately after a feed using the oral syringe provided.
Croatian: Doza se daje dojenčadi tijekom ili odmah nakon hranjenja pomoću isporučene oralne šprice.
English: Regarding safety, the CHMP considered that the safety profile is acceptable; the risks identified are those already known for propranolol and can be appropriately managed.
Croatian: Vezano uz sigurnu primjenu, CHMP smatra da je sigurnosni profil prihvatljiv; identificirani rizici su isti rizici koji su već poznati za propranolol i njima se može na odgovarajući način upravljati.
English: Treatment with Hemangiol is started in babies aged five weeks to five months.
Croatian: Liječenje lijekom Hemangiol započinje se u dojenčadi u dobi od pet tjedana do pet mjeseci.
English: The full EPAR and risk management plan summary for Hemangiol can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Hemangiol nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: It will also provide instructions on how to give the medicine correctly, in order to avoid the risk of low blood sugar levels.
Croatian: Dostavit će i upute o ispravnom načinu primjene lijeka kako bi se izbjegao rizik od niskih razina glukoze u krvi.
English: The dose is progressively increased to a maintenance dose of 1.5 mg/kg twice a day.
Croatian: Doza se progresivno povećava do doze održavanja od 1,5 mg/kg dvaput na dan.
English: Treatment should be started by a doctor who has experience in the diagnosis, treatment and management of infantile haemangioma.
Croatian: Liječenje treba započeti liječnik koji ima iskustvo u dijagnostici, liječenju i vođenju infantilnog hemangioma.
English: Treatment with Hemangiol should last for six months and the child should be monitored once a month, in particular for dose adjustments.
Croatian: Liječenje lijekom Hemangiol treba trajati najmanje šest mjeseci, a dijete treba pratiti jednom mjesečno, posebice za potrebe prilagođavanja doze.
English: This is a summary of the European public assessment report (EPAR) for Hemangiol.
Croatian: Ovo je sažetak Europskoga javnog izvješća o ocjeni dokumentacije (EPAR) za lijek Hemangiol.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Hemangiol on 23 April 2014.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje za lijek Hemangiol vrijedi na prostoru Europske unije od 23. travnja 2014.
English: Hemangiol is used in infants with serious complications, such as painful ulcers, scarring and breathing difficulties, who require systemic therapy (treatment which can have an effect on the whole body).
Croatian: Hemangiol se koristi u djece s ozbiljnim komplikacijama, poput bolnih čireva, ožiljaka i poteškoća s disanjem, koja zahtijevaju sistemsku terapiju (liječenje koje može imati utjecaja na cijelo tijelo).
English: Hemangiol was investigated in one main study involving 460 children aged from five weeks to five months at the start of treatment and who had proliferative infantile haemangioma that required systemic therapy.
Croatian: Hemangiol je ispitan u jednom glavnom ispitivanju koje je obuhvatilo 460 djece u dobi od pet tjedana do pet mjeseci na početku liječenja i koji su oboljeli od proliferirajućeg infantilnog hemangioma koji zahtjeva sistemsku terapiju.
English: It is not intended to provide practical advice on how to use Hemangiol.
Croatian: Svrha sažetka nije davati praktične savjete o korištenju lijeka Hemangiol.
English: Why is Hemangiol approved?
Croatian: Zašto je Hemangiol odobren?
English: The study compared different doses of propranolol with placebo (a dummy treatment) and the main measure of effectiveness was based on whether the haemangiomas disappeared completely or almost completely after 6 months of treatment.
Croatian: Ispitivanje je usporedilo različite doze propranolola s placebom (lažnim liječenjem), a glavne mjera djelotvornosti temeljila se na tome jesu li hemangiomi u potpunosti nestali ili gotovo nestali nakon 6 mjeseci liječenja.
English: Other information about Hemangiol
Croatian: Ostale informacije o lijeku Hemangiol
English: What is Hemangiol and what is it used for?
Croatian: Što je Hemangiol i za što se koristi?
English: In around 60% (61 out of 101) of children treated with the most effective dose of Hemangiol (3 mg/kg/day for 6 months), haemangiomas disappeared completely or almost completely compared with around 4% (2 out of 55) in children who received placebo.
Croatian: Kod otprilike 60% (61 od 101) djece liječene najučinkovitijom dozom lijeka Hemangiol (3 mg/kg/dan tijekom 6 mjeseci), hemangiomi u potpunosti nestaju ili gotovo da nestaju u usporedbi s otprilike 4% (2 od 55) u djece koja su primila placebo.
English: What measures are being taken to ensure the safe and effective use of Hemangiol?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Hemangiol?
English: The recommended starting dose of Hemangiol is 0.5 mg per kilogram bodyweight (0.5 mg/kg), twice a day (at least 9 hours apart).
Croatian: Preporučena početna doza lijeka Hemangiol iznosi 0,5 mg po kilogramu tjelesne težine (0,5 mg/kg), dvaput na dan (u razmaku od najmanje 9 sati).
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Hemangiol's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: Povjerenstvo za lijekove za primjenu kod ljudi (CHMP) pri Agenciji odlučilo je da koristi od lijeka Hemangiol nadmašuju s njim povezane rizike te je preporučilo njegovo odobrenje za korištenje u Europskoj uniji.
English: Hemangiol must not be used in: premature babies who have not reached the corrected age of 5 weeks (the corrected age is the age a premature baby would be if he/she had been born on the due date); breastfed children if the mother is being treated with medicines that must not be used with propranolol; children with asthma or with a history of bronchospasm; children with certain diseases of the heart and blood vessels, such as low blood pressure; and children who tend to have low blood sugar levels.
Croatian: Hemangiol se ne smije primjenjivati u: prijevremeno rođene dojenčadi koja nisu dosegnula ispravljenu dob od 5 tjedana (ispravljena dob je dob prijevremeno rođene dojenčadi u slučaju da se on/ona rodio/rodila na odgovarajući datum); dojene djece ako se majka liječi lijekovima koji se ne smiju koristiti zajedno s propranololom; djece oboljele od astme ili s anamnezom bronhospazma; djece oboljele od određenih bolesti srca i krvnih žila, poput niskog srčanog tlaka; i djece koja su sklona niskim razinama glukoze u krvi.
English: Hemangiol is a medicine that contains the active substance propranolol.
Croatian: Hemangiol je lijek koji sadrži djelatnu tvar propranolol.
English: Serious side effects observed with Hemangiol include bronchospasm (temporary narrowing of the airways) and low blood pressure.
Croatian: Ozbiljne nuspojave uočene s lijekom Hemangiol uključuju bronhospazam (privremeno suženje zračnih putova) i niski krvni tlak.
English: The Company will provide caregivers who will give Hemangiol to children with an educational pack to inform them of the need to monitor children for certain side effects and how to manage them.
Croatian: Tvrtka će dostaviti pružateljima skrbi, koji primjenjuju lijek Hemangiol na djecu, edukacijski paket kako bi ih informirala o potrebi praćenja određenih nuspojava i kako njima upravljati.
English: What are the risks associated with Hemangiol?
Croatian: Koji su rizici povezani s lijekom Hemangiol?
English: The most common side effects with Hemangiol (which may affect more than 1 in 10 children) are sleep disorders, respiratory tract infections such as bronchitis (inflammation of the airways in the lungs), diarrhoea and vomiting.
Croatian: Najčešće nuspojave lijeka Hemangiol (kod više od 1 na 10 djece) su poremećaji spavanja, infekcije respiratornog trakta poput bronhitisa (upala zračnih putova u plućima), proljev i povraćanje.
English: A risk management plan has been developed to ensure that Hemangiol is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Hemangiol.
English: The active substance in Hemangiol, propranolol, belongs to a group of medicines called beta-blockers, which have been widely used to treat several conditions in adults, including diseases of the heart and high blood pressure.
Croatian: Djelatna tvar lijeka Hemangiol, propranolol, ubraja se u grupu lijekova naziva beta blokatori, koji su u širokoj primjeni za liječenje nekoliko stanja u odraslih osoba, uključujući bolesti srca i visoki tlak.
English: Hemangiol at a dose of 3 mg/kg per day (given as two separate doses of 1.5 mg/kg) given for 6 months was shown to be more effective than placebo.
Croatian: Dokazano je da je Hemangiol u dozi od 3 mg/kg na dan (primjenjuje se kao dvije zasebne doze od 1,5 mg/kg) tijekom razdoblja od 6 mjeseci bio djelotvorniji od placeba.
English: Although it is not exactly known how Hemangiol works in proliferative infantile haemangioma, it is thought to do so by several mechanisms including narrowing the blood vessels and so decreasing blood supply to the haemangioma, blocking the formation of new blood vessels in the growth, triggering cell death of the abnormal blood vessel cells and blocking the effect of certain proteins (called VEGF and bFGF), which are important for the growth of blood vessels.
Croatian: Iako nije točno poznat način djelovanja lijeka Hemangiol u slučaju proliferirajućeg infantilnog hemangioma, smatra se da lijek djeluje s nekoliko mehanizama, uključujući i sužavanje krvnih žila i smanjivanje opskrbe krvi u hemangiom, blokirajući formiranje novih krvnih žila u fazi rasta, poticanje smrti stanica abnormalnih stanica krvnih žila i blokiranje djelovanja određenih proteina (naziva VEGF i bFGF), koji su važni za rast krvnih žila.
English: It is used to treat children with proliferating infantile haemangioma, which are benign tumours (abnormal non-cancerous growths) of blood vessels.
Croatian: Koristi se za liječenje djece oboljele od proliferirajućeg infantilnog hemangioma, odnosno benignih tumora (abnormalan nekancerogeni rast) krvnih žila.
English: The Committee concluded that Hemangiol was an effective treatment for haemangioma.
Croatian: Povjerenstvo je zaključilo da je Hemangiol djelotvorniji u liječenju hemangioma.